FDA Neutral on Moderna Bid for Booster Ahead of Decisive Meeting

  • 📰 WebMD
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

The FDA is keeping its cards close to the vest when it comes to the potential approval of a booster dose of Moderna’s COVID-19 vaccine.

On Sept. 3, Moderna originally applied for emergency use authorization for a booster for everyone over the age of 12.is not yet authorized for children and teens 12 to 18, and after Pfizer’s bid to give boosters to teens failed, the company revised its request for authorization.

Moderna is now asking the FDA to approve a 50 mg booster, which is half the dose of the original shots, for everyone over the age of 65, and for those ages 18 to 64 who are at greater risk of COVID-19 because of an underlying health condition or who are exposed to the virus frequently at work.The most commonly reported negative reactions after the Moderna booster were mild, and included

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

The Advisory panel unanimously recommended it BUT for certain groups. Quote: 'there’s no evidence that it’s time to open booster doses of either the Moderna or Pfizer vaccine to everybody'

why do we need boosters again i guess the JABs don't work

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 709. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boostersScientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency's criteria to support use of booster doses of its COVID-19 vaccine, possibly because the efficacy of the shot's first two doses has remained strong. “possibly because the efficacy of the shot's first two doses has remained strong.” CAN WE INCLUDE THAT IN THE HEADLINE Long term clinical trials were due to end in 2023, you can’t speed up time, but since/if the $$ is right the FDA will approve it, perhaps they are starting to use their brains a bit, at least there are some sane countries not in on the money/control push Money will be headed in some direction. Then all will be well with the boosters.
Source: Reuters - 🏆 2. / 97 Read more »

Merck asks the FDA to authorize use of its promising COVID-19 pillDrugmaker Merck has asked U.S. regulators to authorize its promising pill protecting against COVID-19, setting the stage for a decision within weeks. this is terrible news Merck makes Ivermectin. An FYI to all you Ivermectin horse deworming propaganda spreading trash talkers...Yes this means you 'Protect against?' Or 'Treat?'
Source: latimes - 🏆 11. / 82 Read more »

Merck asks FDA to authorize antiviral Covid pill for emergency useMerck has asked the FDA to authorize its antiviral Covid pill for emergency use. ScottGottliebMD weighs in: 'I think where the government misstepped is that we didn't invest enough in trying to scale up the manufacturing of therapeutics across the board.' ScottGottliebMD Is the 'emergency' that Covid might start to become less of an issue before Merck can make huge profits on their pill? ScottGottliebMD The nazi Business is the Vaccine ScottGottliebMD I feel so lucky to have you in my life, you are so supportive and caring. I feel like I won a medal I feel impressed with Geoffreypreud
Source: CNBC - 🏆 12. / 72 Read more »

Merck Seeks FDA Authorization for Antiviral COVID-19 PillDrugmaker Merck announced Monday that it submitted an application to the FDA for emergency use authorization of molnupiravir, an experimental antiviral COVID-19 treatment. That’s great 👍 Now the vaccine isn't enough, they got to make more money off us. From vaccine to pills......🤒 There they come again - 'emergency use'.......🤨 And where're the lab rats?🙄
Source: WebMD - 🏆 709. / 51 Read more »

Merck Asks FDA to Authorize Promising Covid-19 PillThe filing comes shortly after data from a late-stage study showed that the antiviral drug, molnupiravir, cut the risk of hospitalization or death by about 50% in high-risk people with mild to moderate Covid-19. US Gov. NIH website 2011: 'IVERMECTIN ... immeasurable beneficial impact in improving the lives of BILLIONS of PEOPLE - being used FREE of charge ... 'wonder drug'' Can we have NEW *EUA* drugs - to ultimately market ... if there's an existing treatment? Does it have the horse paste in it? Why? Just stop watching CNN and it goes away.
Source: WSJ - 🏆 98. / 63 Read more »

Merck asks US FDA to authorize promising anti-COVID pillWASHINGTON (AP) — Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic. The only thing that stops the downward EbbNFlow now is breaking down the inner workings of the major VentureCapital companies with govt insiders. SecRaimondo GinaRaimondo is the a set made case to start with PJCventure PJCventure & ThirdRockV ThirdRockV EndBlindTrusts This is the correct and real medicine for COVID not that spam vaccine. Africa has the lowest vaccine rate in the world and Africa also has thelowest cases in the world. Uk has very highvaccine rate&uk cases r highest per Capita cases in the world,answer is vaccine making it worse
Source: AP - 🏆 728. / 51 Read more »